EP1732512
Innöndunarsamsetning sem inniheldur súlfóalkýletersýklódextrín og barkstera
Status:
Einkaleyfi útrunniðEP appl. date:
31.12.2004EP published:
22.3.2017EP application number:
05704917.3
EP translation filed:
12.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
30.12.2024Expiry date:
30.12.2024
Title:
INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID
Timeline
Today
31.12.2004EP application
22.3.2017EP Publication
12.6.2017Translation submitted
15.7.2017Registration published
30.12.2024Expires
Owner
Name:
CyDex Pharmaceuticals, Inc.Address:
3911 Sorrento Valley Boulevard Suite 110, 92121, San Diego, CA, US
Inventor
Name:
PIPKIN; James, D.Address:
Lawrence, KS, US
Name:
ZIMMERER, Rupert, O.Address:
Lawrence, KS, US
Name:
THOMPSON, Diane, O.Address:
Overland Park, KS, US
Name:
MOSHER, Gerold, L.Address:
Kansas City, mo, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
533628 PDate:
31.12.2003Country:
US
Classification
Categories:
A61K 9/08
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 9.11.2017
Expires: 30.12.2018
Payer: Árnason Faktor
Number: 15
Paid: 6.11.2018
Expires: 30.12.2019
Payer: Árnason Faktor
Number: 16
Paid: 7.11.2019
Expires: 30.12.2020
Payer: Árnason Faktor
Number: 17
Paid: 6.11.2020
Expires: 30.12.2021
Payer: Árnason Faktor ehf.
Number: 18
Paid: 8.11.2021
Expires: 30.12.2022
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.11.2022
Expires: 30.12.2023
Payer: Árnason Faktor ehf.
Number: 20
Paid: 11.12.2023
Expires: 30.12.2024
Payer: Árnason Faktor ehf.